Novanta Inc
NOVT
Market Cap$5.91B
Close$
$50.70
68.9% downside
Current Fair Value
68.9% downsideOvervalued by 68.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.91 Billion |
|---|---|
| Enterprise Value | $6.33 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $1.92 |
| Beta | 1.71 |
| Outstanding Shares | 35,893,906 |
| Avg 30 Day Volume | 149,411 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 85.24 |
|---|---|
| PEG | -433.81 |
| Price to Sales | 6.79 |
| Price to Book Ratio | 9.06 |
| Enterprise Value to Revenue | 7.09 |
| Enterprise Value to EBIT | 51.72 |
| Enterprise Value to Net Income | 91 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.76 |
Revenue Sources
No data
ESG Score
No data
About Novanta Inc
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers ('OEMs') a competitive advantage. Novanta combines deep proprietary technology expertise and com...